Christopher A. Warlick

Papers

Total Citations

H-Index

About

Christopher A. Warlick is a urologic oncologist whose research has significantly advanced the diagnosis and management of prostate cancer. His work centers on improving the accuracy and safety of prostate cancer detection, particularly through the refinement of biopsy techniques. Warlick is best known for his comprehensive review, "Beyond transrectal ultrasound-guided prostate biopsies: available techniques and approaches," which has garnered 13 citations and serves as a critical resource for clinicians navigating the shift from traditional transrectal ultrasound-guided biopsies to more precise, targeted approaches. This contribution highlights his commitment to reducing infection risks and enhancing diagnostic yield. Beyond this, his research explores risk stratification, active surveillance, and the integration of multiparametric MRI in clinical decision-making. With a career dedicated to bridging surgical innovation and patient-centered outcomes, Warlick’s work has influenced urological practice, offering evidence-based pathways for early detection and treatment. His insights continue to guide trainees and practitioners in optimizing care for men with prostate cancer.